Morning, Thursday, 20th February 2020
THIS EVENT IS CPD CERTIFIED
This seminar will consider the next steps for meeting the goals of the UK strategy on tackling antimicrobial resistance (AMR), and for coordination of the global response to AMR.
In light of Public Health England’s recently published Infectious Disease Strategy 2020-2025, which includes goals to make the UK a world leader in tackling AMR, delegates will further assess the priorities for improving infection prevention and control, with discussion expected on:
- supporting the infection prevention workforce,
- developing innovative diagnostic technologies, and
- reducing the transmission of resistant bacteria.
Further sessions will consider the progress of research into AMR, in light of the recent announcement of £5m of UK government funding for international research partnerships, with discussion on funding, impact and supporting innovation to address AMR in humans, animals and the environment.
Delegates will assess the next steps for meeting the goals of the UK Government’s 5-year action plan and 20-year vision for AMR.
Attendees will consider the impact of the plan and the way forward for delivering key ambitions - including strengthening surveillance capacity and collaborating across the human, animal and environmental health sectors.
The conference follows the announcement of the trial of a new payment model for antibiotics by NICE, NHS England and NHS Improvement, which would pay pharmaceutical companies upfront for the value of their medicines rather than by volume of antibiotic used.
Delegates will consider what will be needed from a new payment model to encourage the development of new antimicrobials, whilst ensuring that companies get the return on the investment required to develop new drugs, without incentivising the overuse of antibiotics.
We expect discussion on the Government’s review into overprescribing and how to encourage the appropriate use of antibiotics, looking at increasing patient awareness of AMR, improving diagnostic testing of infections and engaging with clinicians, vets and farmers to reduce antibiotic use.
Further sessions will consider how to support global collaboration, in light of the recent report from the UN Interagency Coordination Group on Antimicrobial Resistance’s No Time to Wait: Securing the future from drug-resistant infections which called for systematic and meaningful engagement across sectors at the global, national and local level.